Immuron Limited (ASX:IMC)
Australia · Delayed Price · Currency is AUD 0.0400
+0.0080 (25.00%)
Oct 29, 2026, 3:12 PM AEDT
Immuron Market Cap
Immuron has a market cap or net worth of 12.91 million as of October 29, 2026. It is the 43,134th most valuable company in the world and the 1,316th biggest in Australia. Its market cap has decreased by 49.00% in one year.
Market Cap
12.91M
Enterprise Value
4.09M
Revenue
7.71M
Global Rank
Country Rank
#1,316 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 14, 1999, Immuron's market cap has decreased from 37.31M to 12.91M, a decrease of -65.38%. That is a compound annual growth rate of -3.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 12.91M | 10.20% |
| Dec 31, 2025 | 11.72M | -35.27% |
| Dec 30, 2024 | 18.10M | 3.20% |
| Dec 29, 2023 | 17.54M | -10.47% |
| Dec 30, 2022 | 19.59M | -14.00% |
| Dec 31, 2021 | 22.78M | -56.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 19.43M |
| Imugene | 18.61M |
| Radiopharm Theranostics | 17.35M |
| ReNerve | 15.51M |
| Noxopharm | 15.05M |
| EZZ Life Science Holdings | 14.59M |
| Patrys | 14.56M |
| Ceryvyn Therapeutics | 13.68M |